Melissa Frey|Annie Ellis|Kristen Zeligs|Eloise Chapman?Davis|Charlene Thomas|Paul J. Christos|Valentin Kolev|Monica Prasad-Hayes|Samantha Cohen|Kevin Holcomb|Stephanie V. Blank
Impact of the coronavirus disease 2019 pandemic on the quality of life for women with ovarian cancer
Cornell University|Ovarian Cancer Research Alliance|SHARE|Icahn School of Medicine at Mount Sinai|Cornell University|Cornell University|Cornell University|Icahn School of Medicine at Mount Sinai|Icahn School of Medicine at Mount Sinai|Icahn School of Medicine at Mount Sinai|Cornell University|Icahn School of Medicine at Mount Sinai
h3backgroundh3 coronavirus disease 2019 pandemic resulted unprecedented challenges oncology community people living cancer treatments interrupted surgeries cancelled regular oncology evaluations rescheduled people cancer physicians must balance plausible fears coronavirus disease 2019 cancer treatment consequences delaying cancer care h3objectiveh3 aim evaluate experience women ovarian cancer coronavirus disease 2019 pandemic h3study designh3 women current previous diagnosis ovarian cancer completed online survey focusing treatment interruptions quality life quality life measured cancer worry scale hospital anxiety depression scale survey distributed survivor networks social media univariate multivariable linear regression analysis used evaluate effect participant characteristics quality life survey scores h3resultsh3 total 603 women 41 states visited survey website march 30 2020 april 13 2020 555 920 completed survey median age 58 years range 2085 time survey completion 217 participants 433 active treatment total 175 participants 33 experienced delay component cancer care ten 263 38 participants scheduled surgery experienced delay 18 83 217 participants scheduled nonsurgical cancer treatment total 133 participants 240 delayed physician appointment 84 151 laboratory tests 53 96 cancerrelated imaging among cohort 886 489 reported significant cancer worry 514 285 borderline abnormal anxiety 265 147 borderline abnormal depression univariate analysis age less 65 years scheduled cancer treatment cancer surgery delay oncology care selfdescribed immunocompromised use telemedicine associated higher levels cancer worry higher anxiety scores associated age less 65 years selfdescribed immunocompromised higher depression scores associated age less 65 years scheduled cancer surgery delay oncology care selfdescribed immunocompromised use telemedicine multivariable linear regression analysis age less 65 selfdescribed immunocompromised independently predictive greater cancer worry anxiety depression delay cancer care predictive anxiety depression h3conclusionh3 coronavirus disease 2019 crisis affecting care patients ovarian cancer surgeries treatments scheduled physician appointments laboratory tests imaging cancelled delayed younger age presumed immunocompromise delay cancer care associated significantly higher levels cancer worry anxiety depression providers must work patients balance competing risks coronavirus disease 2019 cancer recognizing communication critical clinical tool improve quality life times